National Seed-to-Sale Firm BioTrackTHC to Offer Insight at Inaugural #Oklahoma #Cannabis Business Expo
Prospective Oklahoma Cannabis Business Leaders Can Learn About Vertical Integration and Inventory Traceability, Common Violations, CRM and More
TULSA, Okla. - September 10, 2018 (Investorideas.com Newswire) Leading seed-to-sale cannabis software firm BioTrackTHC, a wholly owned subsidiary of Helix TCS, Inc. (OTCQB: HLIX), will provide a special presentation at the Green on Greenwood Health & Wealth Expo in Tulsa on Friday, Sept. 14, at 11am CST.
The business and science-focused Expo is Oklahoma's first educational cannabis event following the voter-approved legalization of medical marijuana in June.
John Jacobs, National Account Executive for BioTrackTHC, has been tapped to speak on the importance of cannabis compliance software to prevent diversion to the black market and how it can help optimize business operations and customer relationship management (CRM).
"The cannabis industry in Oklahoma is something special," Jacobs said. "The rapid movement towards licensing and implementation has been unlike any other state we have seen and this event aligns with BioTrackTHC's mission to deliver the highest level of comprehensive business support and inventory tracking in the marijuana industry for emerging and established markets."
With extensive expertise in agriculture, bulk data and supply-chain analytics, Jacobs will help attendees understand the ins and outs of seed-to-sale software, tracking and compliance. Presentation attendees can learn more about technologically advanced cannabis tracking platforms and cannabis point-of-sale (POS) solutions, along with vertical integration insight, traceability reporting basics, common violations and what to expect from maturing markets.
"Businesses that rely on data-centric solutions are those that will set themselves apart and be best positioned to grow along with Oklahoma's medical marijuana program," Jacobs said.
With an uptime track record of 99.9%, BioTrackTHC currently holds nine government tracking contracts, making it a leading provider of government traceability systems in cannabis. The Company has deep experience in implementing and maintaining both government and private-sector cannabis seed-to-sale systems in medical and adult-use markets. BioTrackTHC's goal is to help the industry thrive by demonstrating that cannabis programs can operate with transparency and accountability, providing peace of mind to stakeholders and ensuring safety for patients and the community. BiotrackTHC recently doubled down on its commitment to providing technology leadership in the seed-to-sale sector of the cannabis industry with the acquisition of a technology development firm that will nearly double their existing development resources.
The Oklahoma Cannabis Business Alliance hosts the Green on Greenwood Health & Wealth Expo at the Greenwood Cultural Center, located near the Oklahoma State University-Tulsa campus.
For more information or to schedule an interview with a BioTrackTHC representative, please contact Shawna McGregor, Grasslands, at 917-971-7852 or firstname.lastname@example.org.
Bio-Tech Medical Software, Inc., through its BioTrackTHC division, develops and provides effective, cutting-edge technology solutions for the emerging medical and recreational cannabis industry. BioTrackTHC currently holds nine government contracts and operates across 30 states, Washington D.C., Puerto Rico, Australia, Canada and Jamaica. Bio-Tech Medical Software, Inc. is a wholly owned subsidiary of Helix TCS Inc. (OTCQB: HLIX). For more information, visit www.biotrack.com. Follow us on Facebook, Twitter and LinkedIn. Sign up for the CannaPulse Newsletter for legislative changes, software updates and more.
Grasslands: A Journalism-Minded Agency
Marijuana / Hemp Stocks
Like Marijuana / Hemp Stocks? View our Marijuana / Hemp Stocks Directory
Join our Group on Linkedin - Marijuana / Hemp Stocks - News and Trends in Green Investing
Global Cannabis Investing - features Investor Ideas Cannabis news
This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release on the Investorideas.com newswire https://www.investorideas.com/News-Upload/
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.